Previous 10 | Next 10 |
home / stock / epwcf / epwcf news
The launch of PulseIR will deliver a data-driven, digital IR marketing platform to enhance IR communications and investor engagement. VANCOUVER, BC / ACCESSWIRE / April 20, 2023 / EMPOWER CLINICS INC (CSE:EPW)(OTC PINK:EPWCF) ("Empower" or the "Company"), an integrated healthcare company - s...
Partnership With Specialist Medical Group Provides Use of its Clinic Facilities, Licensed Physicians and Patient Roster, and Launches Empower As a Site Management Organization in Dallas, TX VANCOUVER, BC / ACCESSWIRE / April 17, 2023 / EMPOWER CLINICS INC (CSE:EPW)(OTCQB:EPWCF) (" Empower " ...
VANCOUVER, BC / ACCESSWIRE / March 21, 2023 / EMPOWER CLINICS INC. (CSE:EPW)(OTC PINK:EPWCF) ("Empower" or the "Company"), an integrated healthcare company - serving patients through medical centers, a medical device company, and with a developing research and clinical trial division, today anno...
2023-03-20 09:07:16 ET Empower Clinics ( OTC:EPWCF ) has cancelled the private placement offering announced on January 23, 2023 . "We have determined it is appropriate to cancel the current LIFE Offering, and we anticipate providing updates on strategic initiatives i...
VANCOUVER, BC / ACCESSWIRE / March 20, 2023 / EMPOWER CLINICS INC. (CSE:EPW)(OTC PINK:EPWCF) ("Empower" or the "Company"), an integrated healthcare company - serving patients through medical centers, a medical device company, and with a developing research and clinical trial division, announces ...
Partnership With Renowned Dr. Bharat Mocherla Rapidly Accelerates In First 30 Days With Formation Of Delaware Joint Venture Company And Identification Of 50+ Principal Investigator Candidates VANCOUVER, BC / ACCESSWIRE / March 7, 2023 / EMPOWER CLINICS INC. (CSE:EPW)(OTC PINK:EPWCF) ("Empower...
This amended news release reproduces the news release filed on February 28, 2023, except that this amended release updates incorrect ticker symbol and listed exchange. 46% year over year increase in gross profit margin and 7% Increase in Revenue VANCOUVER, BC / ACCESSWIRE / February 28, ...
Empower Clinics press release ( OTC:EPWCF ): Q4 GAAP EPS of C$0.01. Revenue of C$0.43M (-62.3% Y/Y). For further details see: Empower Clinics GAAP EPS of C$0.01, revenue of C$0.43M
46% year over year increase in gross profit margin and 7% Increase in Revenue VANCOUVER, BC / ACCESSWIRE / February 28, 2023 / EMPOWER CLINICS INC (CSE:CBDT)(Frankfurt:8EC)(OTCQB:EPWCF) ("Empower" or the "Company") a life sciences healthcare company - serving patients through medical centers...
This amended and restated news release filed on February 27, 2023 reproduces the news release filed on February 2, 2023, except that this amended and restated news release includes the addition of the term of the agreement and the annual fees to be paid for the various services under the agreemen...
News, Short Squeeze, Breakout and More Instantly...
BioHarvest Sciences Inc (CNVCF) is expected to report for quarter end 2023-12-31 QS Energy Inc (QSEP) is expected to report for Q4 2023 NKGen Biotech Inc. (NKGN) is expected to report for Q4 2023 Cal-Maine Foods Inc. (CALM) is expected to report for Q3 2024 Davide Campari (DVDCF) ...
Iochpe-Maxion S.A. ADR (IOCJY) is expected to report for quarter end 2023-12-31 The Alkaline Water Company Inc. (WTER) is expected to report for Q3 2024 Clover Leaf Capital Corp. (CLOE) is expected to report for Q4 2023 Silvergate Capital Corporation Class A (SICP) is expected to repo...
Caleres Inc. (CAL) is expected to report $0.86 for Q4 2024 B Communications Ltd (BCOMF) is expected to report for quarter end 2023-12-31 Dermata Therapeutics Inc. (DRMA) is expected to report for Q4 2023 Core & Main Inc. Class A (CNM) is expected to report $0.34 for Q4 2024 Wi...